Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

A wide range of cognitive deficits, including memory loss associated with hippocampal
dysfunction, have been widely reported in cancer survivors who received chemotherapy …

Cancer and its treatments are associated with increased risk for cancer-related cognitive
impairment (CRCI). Methods and measures used to study and assess self-reported CRCI (sr …

Simple Summary Up to 70% of chemotherapy-treated patients experience problems with
memory and concentration, potentially caused by direct and indirect neurotoxicity, such as …

Cancer-related cognitive impairment (CRCI) refers to a series of cognitive impairment
symptoms associated with alternations in brain structure and function, caused by a non …

Whilst chemotherapy is a widely used anti-cancer treatment, a subset of patients experience
cognitive decline. However, cancer type, treatment regimen, fatigue and anxiety can …

Aims To examine the prevalence and associated factors of chemotherapy‐related cognitive
impairment (CRCI) in older breast cancer survivors (BCS). Design Systematic review. Data …

In Europe, an estimated 4 million new cancer cases were diagnosed in 2020 (ECIS-
European Cancer Information System, 2023). Patients' chances of survival improved …

Background Cancer survivors frequently experience cognitive impairments. This systematic
review assessed animal literature to identify artificial (pharmaceutical) or natural …

Cancer-related cognitive impairment in breast cancer patients exposed to multi-agent
chemotherapy regimens is associated with the apolipoprotein E4 (APOE4) allele. However …